glp-1 supply shortage news november 2025 Pipeline Update: August - Prime Therapeutics GLP-1 Market Size to Hit

This establishment of higher dosing tiers allows for continued progress when weight loss plateaus

This can lower the risk of insulin-associated weight gain and may improve patient adherence

We think a lot about how to change the game, Hern said, noting that individuals with a BMI of 40 or higher have a life expectancy that is 10 to 15 years shorter than those without obesity

Random-effects models were applied, and sensitivity analyses examined result stability

For now, we better focus on the so what?

Those trends make the kinds of trials that researchers like Scioli and Winhusen are doing to prove the therapies can work for many patients with opioid use disorders, not just a few all the more urgent